{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:51:17Z","timestamp":1783666277585,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["No. 2022XQLH154"],"award-info":[{"award-number":["No. 2022XQLH154"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05272-x","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:02:48Z","timestamp":1697785368000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Personalized application of antimicrobial drugs in pediatric patients with augmented renal clearance: a review of literature"],"prefix":"10.1007","volume":"183","author":[{"given":"Wei-Xin","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Qi","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"5272_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-022-01458-9","author":"E Bing","year":"2022","unstructured":"Bing E, Archambault K, Sananikone A, Nguyen KD, Fang YT, Jabamikos C et al (2022) Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study. Int J Clin Pharm. https:\/\/doi.org\/10.1007\/s11096-022-01458-9","journal-title":"Int J Clin Pharm"},{"issue":"11","key":"5272_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/phar.1653","volume":"35","author":"AL Hobbs","year":"2015","unstructured":"Hobbs AL, Shea KM, Roberts KM, Daley MJ (2015) Implications of Augmented Renal Clearance on Drug Dosing in Critically Ill Patients: A Focus on Antibiotics. Pharmacotherapy 35(11):1063\u20131075. https:\/\/doi.org\/10.1002\/phar.1653","journal-title":"Pharmacotherapy"},{"key":"5272_CR3","doi-asserted-by":"crossref","unstructured":"Tsai D (2018) Prevalence of augmented renal clearance and performance of glomerular filtration estimates in Indigenous Australian patients requiring intensive care admission. Anaesth Intensive Care","DOI":"10.1177\/0310057X1804600107"},{"issue":"9","key":"5272_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/PCC.0000000000001264","volume":"18","author":"JN van den Anker","year":"2017","unstructured":"van den Anker JN, Knibbe CAJ, Tibboel D (2017) Augmented Renal Clearance in Critically Ill Pediatric Patients: Does It Impact the Outcome of Pharmacotherapy? Pediatr Crit Care Med 18(9):901\u2013902. https:\/\/doi.org\/10.1097\/PCC.0000000000001264","journal-title":"Pediatr Crit Care Med"},{"key":"5272_CR5","unstructured":"Zhou R, Fang YT, Su D (2019) [Research advances in augmented renal clearance in critically ill children]. Zhongguo Dang Dai Er Ke Za Zhi. 21(10):1055\u20138.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31642444"},{"issue":"6","key":"5272_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00467-019-04205-x","volume":"34","author":"T Van Der Heggen","year":"2019","unstructured":"Van Der Heggen T, Dhont E, Peperstraete H, Delanghe JR, Vande Walle J, De Paepe P et al (2019) Augmented renal clearance: a common condition in critically ill children. Pediatr Nephrol 34(6):1099\u20131106. https:\/\/doi.org\/10.1007\/s00467-019-04205-x","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"5272_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11095-016-2033-y","volume":"34","author":"N Thakkar","year":"2017","unstructured":"Thakkar N, Salerno S, Hornik CP, Gonzalez D (2017) Clinical Pharmacology Studies in Critically Ill Children. Pharm Res 34(1):7\u201324. https:\/\/doi.org\/10.1007\/s11095-016-2033-y","journal-title":"Pharm Res"},{"issue":"5","key":"5272_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/jac\/dkz448","volume":"75","author":"R Anderson","year":"2020","unstructured":"Anderson R, Rhodes A, Cranswick N, Downes M, O\u2019Hara J, Measey MA et al (2020) A nationwide parent survey of antibiotic use in Australian children. J Antimicrob Chemother 75(5):1347\u20131351. https:\/\/doi.org\/10.1093\/jac\/dkz448","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5272_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/jpids\/piy019","volume":"8","author":"M Hufnagel","year":"2019","unstructured":"Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H (2019) High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey. J Pediatric Infect Dis Soc 8(2):143\u2013151. https:\/\/doi.org\/10.1093\/jpids\/piy019","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"9","key":"5272_CR10","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40262-018-0636-7","volume":"57","author":"I Bilbao-Meseguer","year":"2018","unstructured":"Bilbao-Meseguer I, Rodr\u00edguez-Gasc\u00f3n A, Barrasa H, Isla A, Solin\u00eds M (2018) Augmented Renal Clearance in Critically Ill Patients: A Systematic Review. Clin Pharmacokinet 57(9):1107\u20131121. https:\/\/doi.org\/10.1007\/s40262-018-0636-7","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"5272_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40620-013-0036-x","volume":"27","author":"JP Baptista","year":"2014","unstructured":"Baptista JP, Neves M, Rodrigues L, Teixeira L, Pinho J, Pimentel J (2014) Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients. J Nephrol 27(4):403\u2013410. https:\/\/doi.org\/10.1007\/s40620-013-0036-x","journal-title":"J Nephrol"},{"issue":"10","key":"5272_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/phar.2617","volume":"41","author":"DH Rhoney","year":"2021","unstructured":"Rhoney DH, Metzger SA, Nelson NR (2021) Scoping review of augmented renal clearance in critically ill pediatric patients. Pharmacotherapy 41(10):851\u2013863. https:\/\/doi.org\/10.1002\/phar.2617","journal-title":"Pharmacotherapy"},{"issue":"1","key":"5272_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13613-015-0090-8","volume":"5","author":"S Ruiz","year":"2015","unstructured":"Ruiz S, Minville V, Asehnoune K, Virtos M, Georges B, Fourcade O et al (2015) Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission. Ann Intensive Care 5(1):49. https:\/\/doi.org\/10.1186\/s13613-015-0090-8","journal-title":"Ann Intensive Care"},{"issue":"6","key":"5272_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/ta.0000000000001211","volume":"81","author":"JF Barletta","year":"2016","unstructured":"Barletta JF, Mangram AJ, Byrne M, Hollingworth AK, Sucher JF, Ali-Osman FR et al (2016) The importance of empiric antibiotic dosing in critically ill trauma patients: Are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates? J Trauma Acute Care Surg 81(6):1115\u20131121. https:\/\/doi.org\/10.1097\/ta.0000000000001211","journal-title":"J Trauma Acute Care Surg"},{"key":"5272_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12871-015-0043-7","volume":"15","author":"T Steinke","year":"2015","unstructured":"Steinke T, Moritz S, Beck S, Gnewuch C, Kees MG (2015) Estimation of creatinine clearance using plasma creatinine or cystatin C: a secondary analysis of two pharmacokinetic studies in surgical ICU patients. BMC Anesthesiol 15:62. https:\/\/doi.org\/10.1186\/s12871-015-0043-7","journal-title":"BMC Anesthesiol"},{"key":"5272_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.607101","volume":"11","author":"L Dhondt","year":"2020","unstructured":"Dhondt L, Croubels S, De Paepe P, Goethals K, De Cock P, Devreese M (2020) Unraveling the Contribution of Fluid Therapy to the Development of Augmented Renal Clearance in a Piglet Model. Front Pharmacol 11:607101. https:\/\/doi.org\/10.3389\/fphar.2020.607101","journal-title":"Front Pharmacol"},{"issue":"11","key":"5272_CR17","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/cjn.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4(11):1832\u20131843. https:\/\/doi.org\/10.2215\/cjn.01640309","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"5272_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2012.169","volume":"82","author":"GJ Schwartz","year":"2012","unstructured":"Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA et al (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82(4):445\u2013453. https:\/\/doi.org\/10.1038\/ki.2012.169","journal-title":"Kidney Int"},{"issue":"6","key":"5272_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/j.ackd.2017.09.011","volume":"24","author":"AN Mian","year":"2017","unstructured":"Mian AN, Schwartz GJ (2017) Measurement and Estimation of Glomerular Filtration Rate in Children. Adv Chronic Kidney Dis 24(6):348\u2013356. https:\/\/doi.org\/10.1053\/j.ackd.2017.09.011","journal-title":"Adv Chronic Kidney Dis"},{"key":"5272_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05651-w","author":"NJL Smeets","year":"2022","unstructured":"Smeets NJL, Teunissen EMM, van der Velden K, van der Burgh MJP, Linders DE, Teesselink E et al (2022) Glomerular filtration rate in critically ill neonates and children: creatinine-based estimations versus iohexol-based measurements. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-022-05651-w","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"5272_CR21","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jcph.2029","volume":"62","author":"G-M Huang","year":"2022","unstructured":"Huang G-M, Qiu Y, Liu T-T, Lu J-J (2022) Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study. J Clin Pharmacol 62(7):863\u2013872. https:\/\/doi.org\/10.1002\/jcph.2029","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"5272_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40262-018-0682-1","volume":"58","author":"A Beranger","year":"2019","unstructured":"Beranger A, Benaboud S, Urien S, Moulin F, Bille E, Lesage F et al (2019) Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance. Clin Pharmacokinet 58(2):223\u2013233. https:\/\/doi.org\/10.1007\/s40262-018-0682-1","journal-title":"Clin Pharmacokinet"},{"key":"5272_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.630047","volume":"12","author":"B Du","year":"2021","unstructured":"Du B, Zhou Y, Tang BH, Wu YE, Yang XM, Shi HY et al (2021) Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance. Front Pharmacol 12:630047. https:\/\/doi.org\/10.3389\/fphar.2021.630047","journal-title":"Front Pharmacol"},{"key":"5272_CR24","doi-asserted-by":"publisher","unstructured":"de Cacqueray N, Hirt D, Zheng Y, Bille E, Leger PL, Rambaud J et al (2022) Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function. Clin Microbiol Infect 28(10):1389.e1-.e7.\u00a0https:\/\/doi.org\/10.1016\/j.cmi.2022.05.007","DOI":"10.1016\/j.cmi.2022.05.007"},{"issue":"3","key":"5272_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/ftd.0000000000000270","volume":"38","author":"K Hirai","year":"2016","unstructured":"Hirai K, Ihara S, Kinae A, Ikegaya K, Suzuki M, Hirano K et al (2016) Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance. Ther Drug Monit 38(3):393\u2013397. https:\/\/doi.org\/10.1097\/ftd.0000000000000270","journal-title":"Ther Drug Monit"},{"issue":"11","key":"5272_CR26","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1093\/jac\/dkab302","volume":"76","author":"Y Shimamoto","year":"2021","unstructured":"Shimamoto Y, Verstegen RHJ, Mizuno T, Schechter T, Allen U, Ito S (2021) Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations. J Antimicrob Chemother 76(11):2932\u20132940. https:\/\/doi.org\/10.1093\/jac\/dkab302","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5272_CR27","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5863\/1551-6776-25.5.413","volume":"25","author":"SN Avedissian","year":"2020","unstructured":"Avedissian SN, Skochko SM, Le J, Hingtgen S, Harvey H, Capparelli EV et al (2020) Use of Simulation Strategies to Predict Subtherapeutic Meropenem Exposure Caused by Augmented Renal Clearance in Critically Ill Pediatric Patients With Sepsis. J Pediatr Pharmacol Ther 25(5):413\u2013422. https:\/\/doi.org\/10.5863\/1551-6776-25.5.413","journal-title":"J Pediatr Pharmacol Ther"},{"key":"5272_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.768438","volume":"9","author":"P Andre","year":"2021","unstructured":"Andre P, Diezi L, Dao K, Crisinel PA, Rothuizen LE, Chtioui H et al (2021) Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance! Front Pediatr 9:768438. https:\/\/doi.org\/10.3389\/fped.2021.768438","journal-title":"Front Pediatr"},{"key":"5272_CR29","doi-asserted-by":"publisher","unstructured":"Meesters K, Michelet R, Mauel R, Raes A, Van Bocxlaer J, Vande Walle J et al (2018) Results of a Multicenter Population Pharmacokinetic Study of Ciprofloxacin in Children with Complicated Urinary Tract Infection. Antimicrob Agents Chemother 62(9).\u00a0https:\/\/doi.org\/10.1128\/AAC.00517-18","DOI":"10.1128\/AAC.00517-18"},{"key":"5272_CR30","doi-asserted-by":"publisher","unstructured":"Nguyen T, Oualha M, Briand C, Bendavid M, B\u00e9ranger A, Benaboud S et al (2021) Population Pharmacokinetics of Intravenous Ganciclovir and Oral Valganciclovir in a Pediatric Population To Optimize Dosing Regimens. Antimicrob Agents Chemother 65(3). https:\/\/doi.org\/10.1128\/aac.02254-20","DOI":"10.1128\/aac.02254-20"},{"issue":"3","key":"5272_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cmi.2020.04.022","volume":"27","author":"E Salvador","year":"2021","unstructured":"Salvador E, Oualha M, Bille E, Beranger A, Moulin F, Benaboud S et al (2021) Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus. Clin Microbiol Infect 27(3):413\u2013419. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.022","journal-title":"Clin Microbiol Infect"},{"key":"5272_CR32","doi-asserted-by":"publisher","unstructured":"Abdalla S, Briand C, Oualha M, Bendavid M, Beranger A, Benaboud S et al (2020) Population Pharmacokinetics of Intravenous and Oral Acyclovir and Oral Valacyclovir in Pediatric Population To Optimize Dosing Regimens. Antimicrob Agents Chemother 64(12). https:\/\/doi.org\/10.1128\/AAC.01426-20","DOI":"10.1128\/AAC.01426-20"},{"key":"5272_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.865871","volume":"13","author":"N Maximova","year":"2022","unstructured":"Maximova N, Nistico D, Luci G, Simeone R, Piscianz E, Segat L et al (2022) Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients. Front Pharmacol 13:865871. https:\/\/doi.org\/10.3389\/fphar.2022.865871","journal-title":"Front Pharmacol"},{"issue":"9","key":"5272_CR34","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1097\/pcc.0000000000001228","volume":"18","author":"SN Avedissian","year":"2017","unstructured":"Avedissian SN, Bradley E, Zhang D, Bradley JS, Nazer LH, Tran TM et al (2017) Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients. Pediatr Crit Care Med 18(9):e388\u2013e394. https:\/\/doi.org\/10.1097\/pcc.0000000000001228","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"5272_CR35","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s00467-013-2651-0","volume":"29","author":"MF Schreuder","year":"2014","unstructured":"Schreuder MF, Bueters RR, Allegaert K (2014) The interplay between drugs and the kidney in premature neonates. Pediatr Nephrol 29(11):2083\u20132091. https:\/\/doi.org\/10.1007\/s00467-013-2651-0","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"5272_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.sempedsurg.2013.10.008","volume":"22","author":"M Sulemanji","year":"2013","unstructured":"Sulemanji M, Vakili K (2013) Neonatal renal physiology. Semin Pediatr Surg 22(4):195\u2013198. https:\/\/doi.org\/10.1053\/j.sempedsurg.2013.10.008","journal-title":"Semin Pediatr Surg"},{"issue":"1","key":"5272_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00467-018-4120-2","volume":"35","author":"E Dhont","year":"2020","unstructured":"Dhont E, Van Der Heggen T, De Jaeger A, Vande Walle J, De Paepe P, De Cock PA (2020) Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients? Pediatr Nephrol 35(1):25\u201339. https:\/\/doi.org\/10.1007\/s00467-018-4120-2","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"5272_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","volume":"49","author":"AA Udy","year":"2010","unstructured":"Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J (2010) Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet 49(1):1\u201316. https:\/\/doi.org\/10.2165\/11318140-000000000-00000","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"5272_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1177\/0885066618809688","volume":"35","author":"JP Baptista","year":"2020","unstructured":"Baptista JP, Martins PJ, Marques M, Pimentel JM (2020) Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients. J Intensive Care Med 35(10):1044\u20131052. https:\/\/doi.org\/10.1177\/0885066618809688","journal-title":"J Intensive Care Med"},{"issue":"1","key":"5272_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jac\/dkz408","volume":"75","author":"SN Avedissian","year":"2020","unstructured":"Avedissian SN, Rhodes NJ, Kim Y, Bradley J, Valdez JL, Le J (2020) Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU. J Antimicrob Chemother 75(1):162\u2013169. https:\/\/doi.org\/10.1093\/jac\/dkz408","journal-title":"J Antimicrob Chemother"},{"key":"5272_CR41","doi-asserted-by":"crossref","unstructured":"Bauters T, De Moerloose B, Raes A, Schelstraete P, Dhooge C, Bordon V et al (2019) Augmented Renal Clearance Associated with Vancomycin Clearance in Pediatric Hemato-Oncology and Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 25(3). <Go to ISI>:\/\/WOS:000540655500405","DOI":"10.1016\/j.bbmt.2018.12.340"},{"issue":"9","key":"5272_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrneph.2011.92","volume":"7","author":"AA Udy","year":"2011","unstructured":"Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7(9):539\u2013543. https:\/\/doi.org\/10.1038\/nrneph.2011.92","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"5272_CR43","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1007\/s00134-003-1736-9","volume":"29","author":"D Di Giantomasso","year":"2003","unstructured":"Di Giantomasso D, May CN, Bellomo R (2003) Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis. Intensive Care Med 29(10):1774\u20131781. https:\/\/doi.org\/10.1007\/s00134-003-1736-9","journal-title":"Intensive Care Med"},{"issue":"6","key":"5272_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s13054-014-0657-z","volume":"18","author":"AA Udy","year":"2014","unstructured":"Udy AA, Jarrett P, Stuart J, Lassig-Smith M, Starr T, Dunlop R et al (2014) Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. Crit Care 18(6):657. https:\/\/doi.org\/10.1186\/s13054-014-0657-z","journal-title":"Crit Care"},{"issue":"1","key":"5272_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12883-020-01771-8","volume":"20","author":"A Lannou","year":"2020","unstructured":"Lannou A, Carrie C, Rubin S, Cane G, Cottenceau V, Petit L et al (2020) Salt wasting syndrome in brain trauma patients: a pathophysiologic approach using sodium balance and urinary biochemical analysis. BMC Neurol 20(1):190. https:\/\/doi.org\/10.1186\/s12883-020-01771-8","journal-title":"BMC Neurol"},{"issue":"3","key":"5272_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ et al (2011) Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52(3):285\u2013292. https:\/\/doi.org\/10.1093\/cid\/cir034","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5272_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146224","volume":"11","author":"P Men","year":"2016","unstructured":"Men P, Li HB, Zhai SD, Zhao RS (2016) Association between the AUC0-24\/MIC Ratio of Vancomycin and Its Clinical Effectiveness: A Systematic Review and Meta-Analysis. PLoS ONE 11(1):e0146224. https:\/\/doi.org\/10.1371\/journal.pone.0146224","journal-title":"PLoS ONE"},{"issue":"6","key":"5272_CR48","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/cid\/ciaa303","volume":"71","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C et al (2020) Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 71(6):1361\u20131364. https:\/\/doi.org\/10.1093\/cid\/ciaa303","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5272_CR49","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00228-018-2454-0","volume":"74","author":"Y Chen","year":"2018","unstructured":"Chen Y, Wu D, Dong M, Zhu Y, Lu J, Li X et al (2018) Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants. Eur J Clin Pharmacol 74(7):921\u2013930. https:\/\/doi.org\/10.1007\/s00228-018-2454-0","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"5272_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/ftd.0000000000000978","volume":"44","author":"E Amano","year":"2022","unstructured":"Amano E, Tanaka R, Ono H, Tatsuta R, Hashimoto T, Hiramatsu K et al (2022) Association of Vancomycin Trough Concentration and Clearance With Febrile Neutropenia in Pediatric Patients. Ther Drug Monit 44(4):543\u2013551. https:\/\/doi.org\/10.1097\/ftd.0000000000000978","journal-title":"Ther Drug Monit"},{"issue":"6","key":"5272_CR51","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/jcpt.13206","volume":"45","author":"C-L Lv","year":"2020","unstructured":"Lv C-L, Lu J-J, Chen M, Zhang R, Li Q-C, Chen Y-Y et al (2020) Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children. J Clin Pharm Ther 45(6):1278\u20131287. https:\/\/doi.org\/10.1111\/jcpt.13206","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"5272_CR52","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijantimicag.2012.05.025","volume":"40","author":"T Yamada","year":"2012","unstructured":"Yamada T, Nonaka T, Yano T, Kubota T, Egashira N, Kawashiri T et al (2012) Simplified dosing regimens of teicoplanin for patient groups stratified by renal function and weight using Monte Carlo simulation. Int J Antimicrob Agents 40(4):344\u2013348. https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.05.025","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"5272_CR53","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1128\/AAC.00341-09","volume":"53","author":"S Svetitsky","year":"2009","unstructured":"Svetitsky S, Leibovici L, Paul M (2009) Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother 53(10):4069\u20134079. https:\/\/doi.org\/10.1128\/AAC.00341-09","journal-title":"Antimicrob Agents Chemother"},{"key":"5272_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.594562","volume":"11","author":"T Zhang","year":"2020","unstructured":"Zhang T, Sun D, Shu Z, Duan Z, Liu Y, Du Q et al (2020) Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients. Front Pharmacol 11:594562. https:\/\/doi.org\/10.3389\/fphar.2020.594562","journal-title":"Front Pharmacol"},{"issue":"5","key":"5272_CR55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jiac.2016.01.019","volume":"22","author":"H Kato","year":"2016","unstructured":"Kato H, Hamada Y, Hagihara M, Hirai J, Nishiyama N, Koizumi Y et al (2016) Retrospective study of teicoplanin loading regimen that rapidly achieves target 15\u201330 \u03bcg\/mL serum trough concentration. J Infect Chemother 22(5):308\u2013313. https:\/\/doi.org\/10.1016\/j.jiac.2016.01.019","journal-title":"J Infect Chemother"},{"issue":"4","key":"5272_CR56","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/jac\/dkv418","volume":"71","author":"A Versporten","year":"2016","unstructured":"Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H (2016) The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 71(4):1106\u20131117. https:\/\/doi.org\/10.1093\/jac\/dkv418","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"5272_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1585","volume":"5","author":"SF Maarbjerg","year":"2022","unstructured":"Maarbjerg SF, Thorsted A, Friberg LE, Nielsen EI, Wang M, Schroder H et al (2022) Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever. Cancer Rep (Hoboken) 5(10):e1585. https:\/\/doi.org\/10.1002\/cnr2.1585","journal-title":"Cancer Rep (Hoboken)"},{"key":"5272_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13054-016-1255-z","volume":"20","author":"J Zander","year":"2016","unstructured":"Zander J, D\u00f6bbeler G, Nagel D, Maier B, Scharf C, Huseyn-Zada M et al (2016) Piperacillin concentration in relation to therapeutic range in critically ill patients\u2013a prospective observational study. Crit Care 20:79. https:\/\/doi.org\/10.1186\/s13054-016-1255-z","journal-title":"Crit Care"},{"issue":"1","key":"5272_CR59","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/PCC.0b013e3181d90228","volume":"12","author":"I Ceelie","year":"2011","unstructured":"Ceelie I, van der Starre C, Tibboel D, Stol K, Koren G, de Wildt SN (2011) Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med 12(1):e14\u2013e19. https:\/\/doi.org\/10.1097\/PCC.0b013e3181d90228","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"5272_CR60","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1128\/aac.01368-15","volume":"59","author":"PA De Cock","year":"2015","unstructured":"De Cock PA, Standing JF, Barker CI, de Jaeger A, Dhont E, Carlier M et al (2015) Augmented renal clearance implies a need for increased amoxicillin-clavulanic acid dosing in critically ill children. Antimicrob Agents Chemother 59(11):7027\u20137035. https:\/\/doi.org\/10.1128\/aac.01368-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5272_CR61","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","volume":"23","author":"R Guilhaumou","year":"2019","unstructured":"Guilhaumou R, Benaboud S, Bennis Y, Dahyot-Fizelier C, Dailly E, Gandia P et al (2019) Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d\u2019Anesthesie et Reanimation-SFAR). Crit Care 23(1):104. https:\/\/doi.org\/10.1186\/s13054-019-2378-9","journal-title":"Crit Care"},{"issue":"7","key":"5272_CR62","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmi.2019.03.010","volume":"25","author":"S Weis","year":"2019","unstructured":"Weis S, Kesselmeier M, Davis JS, Morris AM, Lee S, Scherag A et al (2019) Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 25(7):818\u2013827. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.010","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"5272_CR63","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/cid\/ciu069","volume":"58","author":"AJ Hsu","year":"2014","unstructured":"Hsu AJ, Tamma PD (2014) Treatment of multidrug-resistant Gram-negative infections in children. Clin Infect Dis 58(10):1439\u20131448. https:\/\/doi.org\/10.1093\/cid\/ciu069","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5272_CR64","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","volume":"68","author":"CM Baldwin","year":"2008","unstructured":"Baldwin CM, Lyseng-Williamson KA, Keam SJ (2008) Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 68(6):803\u2013838. https:\/\/doi.org\/10.2165\/00003495-200868060-00006","journal-title":"Drugs"},{"issue":"1","key":"5272_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00228-019-02761-7","volume":"76","author":"M Rapp","year":"2020","unstructured":"Rapp M, Urien S, Foissac F, B\u00e9ranger A, Bouazza N, Benaboud S et al (2020) Population pharmacokinetics of meropenem in critically ill children with different renal functions. Eur J Clin Pharmacol 76(1):61\u201371. https:\/\/doi.org\/10.1007\/s00228-019-02761-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"5272_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2052-0492-2-31","volume":"2","author":"S Sunder","year":"2014","unstructured":"Sunder S, Jayaraman R, Mahapatra HS, Sathi S, Ramanan V, Kanchi P et al (2014) Estimation of renal function in the intensive care unit: the covert concepts brought to light. J Intensive Care 2(1):31. https:\/\/doi.org\/10.1186\/2052-0492-2-31","journal-title":"J Intensive Care"},{"key":"5272_CR67","doi-asserted-by":"publisher","unstructured":"Avedissian SN, Rohani R, Bradley J, Le J, Rhodes NJ (2021) Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches. Antimicrob Agents Chemother 65(4). https:\/\/doi.org\/10.1128\/aac.02629-20","DOI":"10.1128\/aac.02629-20"},{"issue":"8","key":"5272_CR68","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/jac\/dkq211","volume":"65","author":"SA Zelenitsky","year":"2010","unstructured":"Zelenitsky SA, Ariano RE (2010) Support for higher ciprofloxacin AUC 24\/MIC targets in treating Enterobacteriaceae bloodstream infection. J Antimicrob Chemother 65(8):1725\u20131732. https:\/\/doi.org\/10.1093\/jac\/dkq211","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"5272_CR69","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40272-022-00513-2","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Chen Z, Huang L, Liu Z, Shi Y, Zhang M et al (2022) Safety of Quinolones in Children: A Systematic Review and Meta-Analysis. Paediatr Drugs 24(5):447\u2013464. https:\/\/doi.org\/10.1007\/s40272-022-00513-2","journal-title":"Paediatr Drugs"},{"key":"5272_CR70","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ijid.2020.08.010","volume":"100","author":"M Moni","year":"2020","unstructured":"Moni M, Sudhir AS, Dipu TS, Mohamed Z, Prabhu BP, Edathadathil F et al (2020) Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study. Int J Infect Dis 100:497\u2013506. https:\/\/doi.org\/10.1016\/j.ijid.2020.08.010","journal-title":"Int J Infect Dis"},{"issue":"11","key":"5272_CR71","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/cid\/ciz067","volume":"69","author":"MH Ooi","year":"2019","unstructured":"Ooi MH, Ngu SJ, Chor YK, Li J, Landersdorfer CB, Nation RL (2019) Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens. Clin Infect Dis 69(11):1962\u20131968. https:\/\/doi.org\/10.1093\/cid\/ciz067","journal-title":"Clin Infect Dis"},{"issue":"3","key":"5272_CR72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4103\/1319-2442.157306","volume":"26","author":"M Fila","year":"2015","unstructured":"Fila M, Dechartes A, Maisin A, Dossier C, Zhao W, Desch\u00eanes G et al (2015) Comparison between valganciclovir and aciclovir\/valaciclovir for CMV prophylaxis in pediatric renal transplantation. Saudi J Kidney Dis Transpl 26(3):453\u2013459. https:\/\/doi.org\/10.4103\/1319-2442.157306","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"9","key":"5272_CR73","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/aas.13658","volume":"64","author":"E Helset","year":"2020","unstructured":"Helset E, Nord\u00f8y I, Sporsem H, Bakke VD, Bugge JF, Gammelsrud KW et al (2020) Factors increasing the risk of inappropriate vancomycin therapy in ICU patients: A prospective observational study. Acta Anaesthesiol Scand 64(9):1295\u20131304. https:\/\/doi.org\/10.1111\/aas.13658","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"5272_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.accpm.2017.12.003","volume":"37","author":"C Dahyot-Fizelier","year":"2018","unstructured":"Dahyot-Fizelier C, Marchand S, Lipman J (2018) Is augmented renal clearance the Holy Grail of antibiotic therapy failure in ventilator-acquired pneumonia? Anaesth Crit Care Pain Med 37(1):5\u20136. https:\/\/doi.org\/10.1016\/j.accpm.2017.12.003","journal-title":"Anaesthesia Critical Care & Pain Medicine"},{"key":"5272_CR75","unstructured":"He C-Y, Qin Y-R, Liu C-J, Ren J, Fan J-S (2019) Effect of augmented renal clearance on plasma concentration of vancomycin and treatment outcome in children with methicillin-resistant Staphylococcus aureus infection. Zhongguo dang dai er ke za zhi = Chin J Contemp Pediatr 21(9):904\u20139. <Go to ISI>:\/\/MEDLINE:31506151"},{"issue":"7","key":"5272_CR76","doi-asserted-by":"publisher","first-page":"E309","DOI":"10.1097\/pcc.0000000000002951","volume":"23","author":"T Van der Heggen","year":"2022","unstructured":"Van der Heggen T, Dhont E, Willems J, Herck I, Delanghe JR, Stove V et al (2022) Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome*. Pediatr Crit Care Med 23(7):E309\u2013E318. https:\/\/doi.org\/10.1097\/pcc.0000000000002951","journal-title":"Pediatr Crit Care Med"},{"key":"5272_CR77","unstructured":"Shimamoto Y, Mizuno T, Verstegen R, Allen U, Ito S (2020) VANCOMYCIN PHARMACOKINETICS IN PEDIATRIC PATIENTS WITH FEBRILE NEUTROPENIA (FN): EFFECT OF AUGMENTED RENAL CLEARANCE (ARC). Clin Pharmacol Ther 107:S105-S. <Go to ISI>:\/\/WOS:000513341300367"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05272-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05272-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T05:12:42Z","timestamp":1707455562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05272-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["5272"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05272-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"10 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors approved the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}